dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1187588006

Production

Component

The component that hold information about this concept.

Fully Specified Name (FSN)

Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)

Shortest Term

Spironolactone 50 mg and torsemide 20 mg oral tablet

Definition Status

900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|

Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Summary

Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)

SCTID: 1187588006, Defined, Active

1187588006|Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)|

en Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)
en Spironolactone 50 mg and torasemide 20 mg oral tablet
en Spironolactone 50 mg and torsemide 20 mg oral tablet

Expression

1187588006 |Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)|
 === 421026006 |Conventional release oral tablet (dose form)| + 
732936001 |Tablet (unit of presentation)| + 
1187579002 |Product containing only spironolactone and torasemide in oral dose form (medicinal product form)| : 
        { 732943007 |Has basis of strength substance (attribute)| = 108476002 |Torasemide (substance)|,
762949000 |Has precise active ingredient (attribute)| = 108476002 |Torasemide (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 387078006 |Spironolactone (substance)|,
762949000 |Has precise active ingredient (attribute)| = 387078006 |Spironolactone (substance)|,
732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        

Diagram

Active

Component help	Language Code help	Type	Term help	Case Significance help	Acceptability	Active
4674248019 - Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug) (en) View
4674248019	en	Fully specified name (core metadata concept)	Product containing precisely spironolactone 50 milligram and torasemide 20 milligram/1 each conventional release oral tablet (clinical drug)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
4674247012 - Spironolactone 50 mg and torasemide 20 mg oral tablet (en) View
4674247012	en	Synonym (core metadata concept)	Spironolactone 50 mg and torasemide 20 mg oral tablet	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Acceptable	True
4674249010 - Spironolactone 50 mg and torsemide 20 mg oral tablet (en) View
4674249010	en	Synonym (core metadata concept)	Spironolactone 50 mg and torsemide 20 mg oral tablet	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (14975654022) - 1187588006 -> 830116007 (766939001) View
766939001 \|Plays role (attribute)\|	830116007 \|Loop diuretic therapeutic role (role)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (14975655023) - 1187588006 -> 897675004 (766939001) View
766939001 \|Plays role (attribute)\|	897675004 \|Potassium-sparing diuretic therapeutic role (role)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (14975650029) - 1187588006 -> 1187579002 (116680003) View
116680003 \|Is a (attribute)\|	1187579002 \|Product containing only spironolactone and torasemide in oral dose form (medicinal product form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975651025) - 1187588006 -> 421026006 (411116001) View
411116001 \|Has dose form (attribute)\|	421026006 \|Conventional release oral tablet (dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975652021) - 1187588006 -> 732936001 (763032000) View
763032000 \|Has unit of presentation (attribute)\|	732936001 \|Tablet (unit of presentation)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975656024) - 1187588006 -> 108476002 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	108476002 \|Torasemide (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975657026) - 1187588006 -> 108476002 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	108476002 \|Torasemide (substance)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975659028) - 1187588006 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975661021) - 1187588006 -> 732936001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	732936001 \|Tablet (unit of presentation)\|	1	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975662025) - 1187588006 -> 387078006 (762949000) View
762949000 \|Has precise active ingredient (attribute)\|	387078006 \|Spironolactone (substance)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975663024) - 1187588006 -> 387078006 (732943007) View
732943007 \|Has basis of strength substance (attribute)\|	387078006 \|Spironolactone (substance)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975665028) - 1187588006 -> 258684004 (732945000) View
732945000 \|Has presentation strength numerator unit (attribute)\|	258684004 \|Milligram (qualifier value)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (14975667020) - 1187588006 -> 732936001 (732947008) View
732947008 \|Has presentation strength denominator unit (attribute)\|	732936001 \|Tablet (unit of presentation)\|	2	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
1187579002 View
1187579002	Product containing only spironolactone and torasemide in oral dose form (medicinal product form)	Spironolactone and torsemide only product in oral dose form	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
421026006 View
421026006	Conventional release oral tablet (dose form)	Oral tablet	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
732936001 View
732936001	Tablet (unit of presentation)	Tablet	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active

Reference Set help	Map Target help	Map Rule help	Map Advice help	Correlation help	Map Category help

Terminology chevron_right Concepts chevron_right 1187588006

Descriptions

Relationships

Parent Concepts

Children Concepts

Extended Maps

Recent searches